January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreNovember 01, 2025
Based on market forecasts, the osteoarthritis sector will expand from USD 9.32 billion in 2024 to USD 20.88 billion by 2034, experiencing a CAGR of 8.4%. In 2023, knee osteoarthritis led the market with a 49% share due to its high prevalence. Imaging tests dominated diagnostics, while North America held a 38% market share. Key players include Zimme...
November 01, 2025
According to forecasts, the global respiratory drugs market will grow from USD 17.53 billion in 2024 to USD 30.81 billion by 2034, with an expected CAGR of 5.8%. In 2023, COPD was the most common respiratory disorder, leading the market with a 36% share. Bronchodilators dominated treatment options with a 40% share. Hospital pharmacies were the top ...
November 01, 2025
The carpal tunnel syndrome market is growing due to rising cases linked to arthritis, hormonal changes, and more. Innovations like AI improve detection, while ongoing research drives new treatments. Regional trends vary, with North America focusing on awareness and Asia Pacific tackling underdiagnosis challenges....
November 01, 2025
Market insights predict, the epilepsy drugs industry is expected to grow from USD 9.98 billion in 2024 to USD 16.42 billion by 2034, driven by a CAGR of 5.1%. Epilepsy drugs help control seizures by stabilizing brain activity. They work by reducing excessive nerve signaling, preventing sudden electrical bursts that cause seizures. These medications...
November 01, 2025
According to market projections, the global liver cancer drugs market, valued at USD 3.05 billion in 2024, is anticipated to reach USD 11.5 billion by 2034, growing at a CAGR of 14.2% over the next decade. Liver cancer drugs are medicines used to treat liver cancer by stopping cancer cell growth, shrinking tumors, or boosting the immune system to f...
November 01, 2025
According to forecasts, the global antipsychotic drugs market will grow from USD 19.45 billion in 2024 to USD 41.21 billion by 2034, with an expected CAGR of 7.8%. Antipsychotic drugs help manage symptoms of mental health conditions like schizophrenia and bipolar disorder. They work by balancing brain chemicals to reduce hallucinations, delusions, ...
November 01, 2025
According to forecasts, the global musculoskeletal disorders treatment market will grow from USD 197.18 billion in 2024 to USD 353.12 billion by 2034, with an expected CAGR of 6%. Musculoskeletal disorder treatment includes pain relief, physical therapy, medications, and lifestyle changes to improve movement and function. In severe cases, surgery m...
November 01, 2025
Based on market forecasts, the inflammatory bowel disease treatment sector will expand from USD 21.01 billion in 2024 to USD 35.88 billion by 2034, experiencing a CAGR of 5.5%. The Inflammatory Bowel Disease (IBD) treatment market focuses on medications, biologics, and therapies for conditions like Crohn’s disease and ulcerative colitis. Grow...
November 01, 2025
According to market projections, the cancer vaccines sector is expected to grow from USD 11.38 billion in 2024 to USD 33.61 billion by 2034, reflecting a CAGR of 11.44%. The increasing prevalence of cancer, research and development and continuous efforts taken by governments and key stakeholders drive the market's growth....
November 01, 2025
Market insights predict the global non-small lung carcinoma industry will increase from USD 9.1 billion in 2024 to USD 23.67 billion by 2034, achieving a CAGR of 10.03%. Clinical research, development of new treatment options, and prevalence of NSCLC is driving the growth of the market....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com